Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation=> Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

Rao, MP; Halvorsen, S; Wojdyla D., Thomas L.; Alexander, JH; Hylek, EM; Hanna M., Bahit; MC, Lopes; RD, De Caterina R; Erol, C; Goto S., Lanas F.; Lewis, BS; Husted, S; Gersh, BJ; Wallentin L., Granger

Más información

Título de la Revista: Journal of the American Heart Association
Volumen: 4
Asunto: 12
Editorial: John Wiley and Sons Inc.
Fecha de publicación: 2015
DOI/URL:

10.1161/JAHA.115.002015